Document is current
Any future updates will be listed below
-
Authors
Garfall, Alfred L. https://orcid.org/0000-0003-2791-5748
- License Information
-
More Information
Article History
Received: 5 September 2024
Revised: 25 November 2024
Accepted: 3 December 2024
First Online: 3 January 2025
Competing interests
: The author discloses the following relationships: Consulting (Abbvie, Regeneron, Johnson & Johnson, Novartis, Smart Immune, Bristol Myers Squibb, Gracell); DSMB service (Johnson & Johnson); research funding (Johnson & Johnson, Novartis, CRISPR Therapeutics).
